Daniel S. Goldman sold Madrigal Pharmaceuticals Inc (NASDAQ: MDGL)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Madrigal Pharmaceuticals Inc (MDGL) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) on April 10, 2023. Since that trade, MDGL is up +122.92% against the S&P 500 up +85.07%, an outperformance of +37.85%.
Data updated
Daniel S. Goldman's MDGL trades vs the price
MDGL is up +122.92% since Daniel S. Goldman sold on April 10, 2023, versus +85.07% for the S&P 500.
Performance since this trade
All Daniel S. Goldman MDGL trades
Daniel S. Goldman & MDGL trading FAQ
Is it legal for Daniel S. Goldman to trade Madrigal Pharmaceuticals Inc (MDGL) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Madrigal Pharmaceuticals Inc (MDGL), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell MDGL?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Madrigal Pharmaceuticals Inc (MDGL) on April 10, 2023, according to public STOCK Act filings.
How has MDGL performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold MDGL on April 10, 2023, the stock is up +122.92%, versus +85.07% for the S&P 500 over the same period, an outperformance of +37.85%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MDGL trades?
Quantellect tracks every disclosed congressional trade in Madrigal Pharmaceuticals Inc (MDGL) on the Madrigal Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's MDGL tradesAll congressional filings for Madrigal Pharmaceuticals IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.